Similar with our findings in GBM, the expression level of chemerin in tumor tissue or serum is negatively correlated with patient survival in cancers such as breast cancer [43, 44], ovarian cancer [45], and non-small cell lung cancer [46]. Here, RARRES2 is linked to non-small cell lung carcinoma.